Product
Keppra
1 clinical trial
3 indications
Indication
Hematologic DisordersIndication
HemoglobinopathiesIndication
ImmunodeficienciesClinical trial
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)Status: Recruiting, Estimated PCD: 2024-06-01